Journal
ARCHIVES OF TOXICOLOGY
Volume 88, Issue 8, Pages 1491-1502Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00204-014-1234-6
Keywords
Metabolomics; Xenobiotic metabolism; Toxicology; Pathogenesis
Categories
Funding
- Intramural Research Program of the Center for Cancer Research, National Cancer Institute
- National Institutes of Health [1R01ES022186-01]
Ask authors/readers for more resources
Liquid chromatography-mass spectrometry (LC-MS)-based metabolomics can have a major impact in multiple research fields, especially when combined with other technologies, such as stable isotope tracers and genetically modified mice. This review highlights recent applications of metabolomic technology in the study of xenobiotic metabolism and toxicity, and the understanding of disease pathogenesis and therapeutics. Metabolomics has been employed to study metabolism of noscapine, an aryl hydrocarbon receptor antagonist, and to determine the mechanisms of liver toxicities of rifampicin and isoniazid, trichloroethylene, and gemfibrozil. Metabolomics-based insights into the pathogenesis of inflammatory bowel disease, alcohol-induced liver diseases, non-alcoholic steatohepatitis, and farnesoid X receptor signaling pathway-based therapeutic target discovery will also be discussed. Limitations in metabolomics technology such as sample preparation and lack of LC-MS databases and metabolite standards, need to be resolved in order to improve and broaden the application of metabolomic studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available